8-K Q2 2020 EARNINGS RELEASE

Company

ENANTA PHARMACEUTICALS INC

Filed

May 6, 2020

Period of Report

May 6, 2020

Accession Number

0001564590-20-021925

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →